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BVDV GENETIC DIVERSITY, BIOTYPES, VIRULENCE AND GEOGRAPHICAL DIFFERENCES 
Bovine viral diarrhea is a disease of cattle caused by one of three Pestivirus species; bovine viral diarrhea 
virus 1 (BVDV‐1), bovine viral diarrhea virus 2 (BVDV‐2) and HoBi‐like virus (often referred to as BVDV‐3 
or bovine atypical pestivirus [1]. Recently, a proposed change of names of the Pestivirus species was 
presented to provide a more uniform naming system.  There are 11 recognized species, A through K, 
where BVDV1, BVDV2, and HoBi-like virus are Pestivirus A, B, and H respectively [31].  Bovine 
pestiviruses belong to the family Flaviviridae, and are single‐stranded, enveloped RNA viruses similar to 
classical swine fever virus (CSFV) in pigs and border disease virus (BDV) in sheep. Phylogenetic analysis 
of the three bovine pestiviruses further classified them into sub‐genotypes and identified at least 21 
BVDV‐1 (1a–1u), three BVDV‐2 and four HoBi‐like subgroups [21, 32]. Bovine pestiviruses can exist as 
two biotypes; non‐cytopathic (ncp) or cytopathic (cp). In the field, the ncp biotype has been shown to 
predominate, but a mutation of the persisting ncp strain can give rise to cp virus in PI animals resulting 
in the development of mucosal disease (MD), [4, 24]. Both ncp BVDV‐1 and BVDV‐2 have been isolated 
following outbreaks of severe acute infections associated with hemorrhagic disease; however, severe 
acute infections have only been reproduced under experimental conditions with ncp BVDV‐2 strains 
[27]. Highly virulent BVDV‐2 strains are the minority in the field and the majority of BVDV‐2 strains are 
no more virulent than the BVDV‐1 or HoBi‐like virus strains. The understanding of virulence factors and 
the difference in virulence between bovine pestiviruses are not yet fully understood, but insertions have 
been implicated to play a role. 
 
PATHOGENESIS 
The clinical manifestation of acute BVD infections can vary and are dependent on the infecting viral 
strain as well as the age, immunological status and reproductive status of the animal when infected. 
Naïve calves and non‐pregnant adult cattle acutely infected with BVD typically present with no or only 
minimal clinical signs such as; fever, decreased appetite and diarrhea [11]. Acute BVD infections have 
been shown to cause a reduction in circulating white blood cells (WBC) between 3 and 14 days after 
infection and are also associated with a transient depletion of lymphoid tissues [6, 7, 16]. This reduction 
in WBC and depletion of lymphoid tissues is associated with immune modulation that may lead to 
increased susceptibility of infected animals to secondary infections, such as mastitis and bovine 
respiratory disease complex (BRDC) [10, 13].  
 
Acute infections of naïve dams during pregnancy can have more severe implications. The unique ability 
of pestiviruses to cross the placenta and infect the developing fetus has been shown to lead to a wide 
array of reproductive losses. The outcome of BVDV fetal infections is largely dependent on the 
gestational age of the fetus at the time of exposure.  Early infection within approximately the first 40 
day frequently leads to death of the fetus, while infection after approximately 150 days of gestation 
leads to transient infection (TI) which is cleared by a fetal immune response [11].  
 
Persistent infections can only be established before the immune system is able to discriminate between 
self and non-self-antigens [11, 18].  This window of opportunity for persistent infection corresponds to 
approximately 40-125 days gestation [11, 18]. While infections during early and late gestation can still 
lead to economical losses, infections that lead to PI calves are a major concern due to PI animals 
excreting virus in most bodily fluids, throughout their lives and are, as a result, critical for the 
maintenance and circulation of bovine pestiviruses in the field.  
 
TRANSMISSION 
Persistently infected animals have been regarded as the major reservoir of bovine pestiviruses since 
they shed large quantities of virus through almost all bodily excretions and secretions, for the entirety of 
their lives. Other methods of transmission for bovine pestiviruses can include: animal trade (purchase of 
PIs or Trojan Dams), common pasturing (including cattle and domestic small ruminants), grouping of 
animals from different sources (such as in sale barns and feedlots), contact between domestic and wild 
species and other cattle management strategies that increases the likelihood of between herd contacts. 
Bovine pestiviruses have also been shown to spread due to indirect contact with infected animals 
through contaminated bedding, fomites, equipment, machinery and personnel including veterinarians 
[20, 22], the use of contaminated biological products such as semen, vaccines or FBS and non‐bovine 
reservoir hosts [19]. While PI animals are considered the major source of infection in a herd, acutely 
infected cattle may also be a source of transmission. The length of time animals are infectious due acute 
infections can vary based on the health, stress level and age of the animal as well as the presence of 
other pathogens [3, 8, 26]. In addition, it has been reported that many non‐bovine species are 
susceptible to infections with BVDV‐1, BVDV‐2 and HoBi‐like pestivirus. Implications of infections in non‐
bovine species to cattle is an important area of research to better understand for implementation of 
control and eradication programs for BVD as these species could facilitate transmission of the virus in 
naïve populations.  
 
CONTROL AND TESTING 
The fundamental principle of any BVD control and eradication programs is to reduce the prevalence of 
PI animals in a population and prevent the creation of new PI animals. This can be achieved by; (a) Test‐
and‐Cull, to identify and remove PI animals; (b) Improvements to Biosecurity, to reduce virus 
transmission in to a population and/or (c) Vaccination, to protect the fetus from infection and thus 
reduce PI development [5, 17]. The degree with which the disease is reduced is different for control 
compared to eradication programs [5, 12]. Control programs aim to reduce disease prevalence to a 
relatively low and manageable level while eradication programs aim to provide a continued absence of 
the disease in the population [5, 12]. Both goals, in regard to BVD, have been shown to be achievable [5, 
30] and can be undertaken either at the national, regional or individual farm level. Success in either 
control of eradication programs for bovine pestiviruses is dependent on; effectively differentiating 
between animals that are susceptible to infection, undergoing acute transient infection, recovered from 
acute transient infection, or are PI is critical. Current diagnostic testing for bovine pestiviruses is used to 
identify either virus‐specific antibodies (Ab), virus‐specific antigen (Ag), RNA or the virus itself [28]. 
 
 
  
 
POTENTIAL LIMITATIONS ASSOCIATED WITH TESTING AND CONTROL 
While the ultimate goal of BVD control and eradication programs are to reduce the prevalence of PI 
animals in a population and prevent the creation of new PI animals. The methods used for testing to 
identify and remove PI animals as well as vaccination as a means to reduce virus transmission in to a 
population and thereby reduce PI development [5], are both more so insurance plans rather than 
providing a 100% guarantee. As control and eradication programs are developed, variables associated 
with lack of detection and lack of protection should be considered. A potential variable associated lack 
of detection includes maternal antibodies interference in PI calves with diagnostic testing [9, 14, 15]. 
This interference could lead to false-negative results, a phenomenon known as “colostral diagnostic 
gap”. Furthermore, BVDV isolation from blood samples of PI calves is inhibited by maternal neutralizing 
antibodies for several weeks [2]. The colostral diagnostic gap is less pronounced to produce false-
negative results when the ELISA’s is for the soluble BVDV-Erns in blood sera rather than with the NS3-
capture ELISA [29]. BVDV-specific PCR with blood samples is believe to be a reliable method for testing 
PI animal also in the presence of colostral antibodies. For antigen capture ELISAs with skin samples, the 
detection of secreted soluble BVDV-Erns seems to be a most suitable, but a significant proportion of 
false-negatives were observed by European BVDV control programs [23, 25].  
 
The exact reasons contributing to diagnostic failure are generally unknown, but maternal antibody 
interference could be one potential explanation. Other potential explanations may include the amount 
of virus being shed from PI animals at the time of sampling. PI calves can shed large amount of virus, but 
the amount of virus being shed is not constant over time and can viral titers in samples can vary over 
time. Another potential explanation for false-negatives is the genetic diversity associated with bovine 
pestiviruses. While BVDV-Erns is largely conserved, there could be point mutations causing a change in 
the amino acid in particular isolates that impact binding affinity, as observed with other target proteins 
used for diagnostics. An non-typical example of lack of detection associated with the Erns protein is in 
pregnant dams vaccinated with Npro and Erns double deleted mutant BVDV vaccine giving rise to PI 
calves due to incorporation of the vaccine virus. Given that the major skin based ELISAs are Erns based, 
the lack of these proteins does allow for detection of PI calves that are infected with this particular 
vaccine virus containing the deletion. Furthermore, inherent genetic variability in pestiviruses may play a 
role in detection and this could be further compounded, as genetic variability can be associated with 
geographical differences in pestiviruses. Additionally, the relationship between genetic and antigenic 
differences can be associated with lack of protection as it relates to vaccination. A clear understanding 
of potential reasons associated with false-negative results are needed to better implement testing 
programs that are responsive to limitations associated with our current diagnostic tests.   
 
For a complete review the following papers are suggested as these papers were used to help collectively 
consolidate the information used in the presentation and to prepare this supplemental information. 
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